38例川畸临床分析
摘要
目的探讨川畸病的诊断及有效治疗措施。方法回顾分析38例川畸病患儿临床表现及治疗效果。结果37例患儿均取得满意疗效，仅1例发生持久性冠状动脉扩张、冠状动脉瘤。讨论早期诊断川畸病，早期静滴大滴量丙种球蛋白+口服阿斯匹林治疗川畸病疗效满意。
参考文献2
-
1许煊.静脉注射丙种球蛋白治疗急性川畸病的前瞻性研究[J].临床儿科杂志,2000,18(3):188-189.
-
2阿日根,高娃,刘春华,李红.川畸病的诊治进展[J].医学综述,2001,7(3):167-170. 被引量：6
二级参考文献10
-
1[1]Niwa K,Aotsuka H,Hamada H,et al. Thrombocytopenta:A risk factor for acute myocardial infarction during the acute Phase of Kawasaki disease. coron Artery Dis, 1995,6: 857-864
-
2[2]Choi IH, Chwae YJ, Shim WP, et al. Clonal expansion of CD+8 T cells in Kawasaki disease. J Immunol, 1997,159:481-486
-
3[3]Kato H, Sugimura T, Akagi T, et al. Long term consequences of kawasaki disease. Circulation, 1994,94:1279-1285
-
4[4]Akagi T, Kato H, Inoue O, et al. Valvular heart disease in kawasaki Syndrome. Incidence and natural history. Am Heart J, 1990,120: 366-372
-
5[5]Burns JC, Shike H, Gordon JB, et al. Sequelae of kawasaki disease in adolescents and young adults. J Am Coll Cardiol, 1996,28: 253-257
-
6[6]Sawaji Y, Haneda N,Yamaguchi S, et al. Risk factors for coronary lesions in acute kawasaki disease. In Kato H (ed): Kawasaki Disease. Elsevier Science, Amsterdam, The Netherlands, 1995,377-380
-
7[7]Rowley AH, Eckerley CA, Jack HM, et al. IgA plasma cells in vascular tissure of patients with kawasaki syndrome. J Immunol, 1997, 159: 5946-5955
-
8[8]Terai M, Shulman ST. Prevalence of coronary artery abnormalities in kawasaki disease is highly dependent on gammaglobulin dose but independent of salicylate dose. J Pediatr, 1997,131: 888-893
-
9[9]Sundel RP, Burns JC, Baker A, et al. Gamma globulin re treatment in kawasaki disease. J Pediatr, 1993,123:657-659
-
10[12]Noto N, Aynsawa M, Karasawa K, et al. Dobutamine stress echocardio graphy for detection of coronary artery stenosis in children with kawasaki disease. J Am Coll Cardiol, 1996,27:1251-1256
共引文献6
-
1宋家华,冉志玲,曾彩琼.川崎病中西医结合诊治的临床分析[J].实用中西医结合临床,2005,5(6):93-94.
-
2曾绮丹,李绍锦.不同剂量丙种球蛋白静脉注射治疗川崎病疗效观察[J].中国现代医药杂志,2006,8(9):28-29. 被引量：2
-
3沈科.不典型川琦氏病28例临床分析[J].中国急救复苏与灾害医学杂志,2009(6):411-412.
-
4杨莉.小儿不典型川崎病28例临床分析[J].重庆医学,2002,31(4):312-313.
-
5段红宝,张京滨,刘静炎.60例川畸病的临床观察及治疗[J].河南医药信息,2002,10(17):29-30.
-
6吴正文.不典型川畸病32例临床分析[J].中原医刊,2003,30(21):8-9.
-
1刘燕.阿奇霉素序贯治疗小儿支原体肺炎的疗效观察[J].临床合理用药杂志,2012,5(24):51-51.
-
2杨治平,赵建美.静滴丙种球蛋白治疗婴幼儿重症肺炎32例[J].南通医学院学报,2002,22(2):218-219. 被引量：1
-
3刘安平.新生儿缺氧缺血性脑病180例临床分析[J].中国民族民间医药,2011,20(7):111-111.
-
4黄希勇,蒋耀辉,祝益民.对难治性川畸病应用皮质激素指征的探讨[J].中国医师杂志,2003,5(S1):207-208.
-
5姜兴源.小儿川畸病27例临床分析[J].辽宁医学杂志,2001,15(1):55-55.
-
6刘捷.川崎病丙种球蛋白使用时机探讨[J].数理医药学杂志,2008,21(3):299-300.
-
7田桂英,王丽萍.大剂量丙种球蛋白对川崎病的疗效[J].民航医学,1996,6(4):26-28.
-
8张翠香,黄建萍,陈冰,姚淑娴,陈泽莹.大理地区川崎病临床特征(附70例分析)[J].大理医学院学报,2000,9(4):46-47.
-
9黄东生,杨蕾,冉崇蓉,钟炎皋,唐锁勤,王航雁,王建文,王淑漪,吕善根,魏晓军,衣京梅,樊秀平.小儿川崎病[J].军医进修学院学报,1999,20(3):196-197. 被引量：1
-
10张玲英,洪华,彭茜.急性期川崎病患儿血清sIL-2R CRP IL-6 IL-8 TNF-α的变化[J].西部医学,2005,17(2):171-172. 被引量：1
